TY - JOUR KW - Adolescent KW - Adult KW - Aged KW - Analgesics, Opioid/economics KW - Buprenorphine/economics KW - Cohort Studies KW - Cost Sharing/statistics & numerical data KW - Female KW - Health Expenditures/statistics & numerical data KW - Humans KW - Insurance, Health/statistics & numerical data KW - Male KW - Medication Adherence/statistics & numerical data KW - Methadone/economics KW - Middle Aged KW - Naltrexone/economics KW - Opiate Substitution Treatment/economics KW - Opioid-Related Disorders/drug therapy/economics KW - United States KW - Young Adult AU - J. R. Morgan AU - E. K. Quinn AU - C. E. Chaisson AU - E. Ciemins AU - N. Stempniewicz AU - L. F. White AU - B. P. Linas AU - A . Y. Walley AU - M. R. Larochelle A1 - AD - Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA.; OptumLabs Visiting Scholar, OptumLabs, Eden Prairie, MN.; Biostatistics and Epidemiology Data Analytics Center, Boston University School of Public Health, Boston, MA.; OptumLabs, Eden Prairie, MN.; American Medical Group Association, Alexandria, VA.; American Medical Group Association, Alexandria, VA.; Departments of Biostatistics.; Epidemiology, Boston University School of Public Health.; Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA.; Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA.; Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, MA. BT - Medical care C5 - Financing & Sustainability; Opioids & Substance Use CP - 3 DO - 10.1097/MLR.0000000000001689 IS - 3 JF - Medical care LA - eng M1 - Journal Article PB - Wolters Kluwer Health, Inc PY - 2022 SN - 1537-1948; 0025-7079; 0025-7079 SP - 256 EP - 263 EP - T1 - Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design T2 - Medical care TI - Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design U1 - Financing & Sustainability; Opioids & Substance Use U2 - 35026792 U3 - 10.1097/MLR.0000000000001689 VL - 60 VO - 1537-1948; 0025-7079; 0025-7079 Y1 - 2022 Y2 - Mar 1 ER -